drugset / Trial / NCT05541250
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)
NaSingle-groupOpen-labelSupportive care
Summary
The primary purpose of this research study is to evaluate the safety and possible harms of injecting one's own Schwann cells along with nerve auto-graft after a severe injury to a major nerve has occurred.
Timeline
- Start
- 2023-05-04
- Primary completion
- 2026-09-29
- Completion
- 2026-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Human Schwann Cell | Cell therapy | 1 ml | — |
| Subject | Autologous Human Schwann Cell | Cell therapy | 8e+07 cells | — |
| Subject | Autologous Human Schwann Cell | Cell therapy | 1e+08 cells | — |